Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Evidence suggests that liraglutide may be implicated in breast cancer progression
The FDA has approved Wegovy (semaglutide 2.4 mg), Zepbound (tirzepatide), and Saxenda (liraglutide 3 mg) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Your physician will recommend semaglutide or tirzepatide based on your health profile, weight loss goals, and medical history
Jessica is by far the most caring person ever
US$ 20.03
US$ 22.45
US$ 27.63
US$ 22.52
